✦ LIBER ✦

Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver

✍ Scribed by Ricky A. Sharma; Martin M. Eatock; Christopher J. Twelves; Gill Brown; Heather R. McLelland; Kathryn T. Clayton; Kenneth J. O'Byrne; Chris Moyses; James Carmichael; William P. Steward

Book ID: 105994726
Publisher: Springer
Year: 2001
Tongue: English
Weight: 92 KB
Volume: 48
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800100332

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical phase II study and pharmacologi

Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer—significant effect of food intake on the bioavailability of the oral camptothecin analogue

✍ P Schöffski; A Herr; J.B Vermorken; J Van den Brande; J.H Beijnen; H Rosing; J V 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 130 KB

1474 POSTER A phase I, open-label study

1474 POSTER A phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB